-
Software Companies Integrate Cancer Analytics, Patient Mgmt
26 May 2015. Two companies with software addressing different perspectives of cancer care agreed to offer an integrated version of their products. Flatiron Health in New York, a developer of cancer analytics, and Varian Medical Systems in Palo Alto, California, a provider of decision support software for cancer care, announced the deal today, but released…
-
Memorial Day 2015
25 May 2015. Today is Memorial Day in the U.S., and Science & Enterprise is observing the holiday. We will return to our regular postings tomorrow. (Photo: A. Kotok) * * *
-
Space Object Taxonomy Sought in $50K Challenge
22 May 2015. A new challenge on InnoCentive seeks a scientifically-based method for describing orbiting space objects with the fewest characteristics possible, but still predicts the objects’ behavior. The competition has a total purse of $50,000 and a deadline for submissions of 20 July 2015. InnoCentive in Waltham, Massachusetts conducts open-innovation, crowdsourcing competitions for corporate…
-
Study IDs Advanced Prostate Cancer Genome Mutations
22 May 2015. An analysis of biopsy samples from men with prostate cancer that spread to other parts of their bodies identifies genomic anomalies found in nearly 90 percent in men with the condition, for which treatments may be available. Findings from the team at eight institutions in the U.S. and U.K. appear today in…
-
Mobile App Data Provided for Chronic Pain Study
21 May 2015. Data collected by a mobile app designed to help individuals manage their pain are being provided to a research lab at York University to reveal patterns in painful experiences by the app’s users. York’s Human Pain Mechanisms Lab in Toronto, Ontario, Canada will analyze data provided by the app Manage My Pain,…
-
Orphan Status Granted Eye Cancer Treatment
21 May 2015. Food and Drug Administration designated an experimental treatment for uveal melanoma, a rare and aggressive form of cancer in the eye, as an orphan drug that qualifies for incentives to expedite its development. Aura Biosciences also revealed results of preclinical tests showing the ability of its lead biologic therapy code-named AU-011 to…
-
Phillips, MIT Form Health Technology Collaboration
20 May 2015. Electronics manufacturer Royal Phillips and Massachusetts Institute of Technology are collaborating on research into health care technology and digital urban lighting systems. The 5-year, $25 million agreement also includes moving the company’s North American research and development center to Cambridge, Massachusetts near the MIT campus. Phillips, headquartered in the Netherlands, designs and…
-
FDA Approves Four-Times-Per-Year Schizophrenia Drug
19 May 2015. Food and Drug Administration approved for sale in the U.S. a drug for controlling schizophrenia symptoms that individuals need to take only four times per year. Janssen Pharmaceuticals, a division of Johnson & Johnson, markets the three-month version of the drug paliperidone palmitate under the brand name Invega Trinza. Schizophrenia is a…
-
Lab-On-Chip Device Captures Circulating Tumor Cells
19 May 2015. Engineers and medical researchers designed a microchip that detects clusters of circulating tumor cells that break away from tumors and can spread cancer throughout the body. The team from a joint Harvard-MIT health sciences technology program and Massachusetts General Hospital in Boston published its findings yesterday in the journal Nature Methods (paid…
-
National Academies to Develop Gene-Editing Guidelines
18 May 2015. National Academy of Sciences and Institute of Medicine plan to write guidelines governing an emerging technology for editing human genomes. The initiative includes an international meeting in the fall to discuss the scientific, ethical, and policy issues associated with the technology known as CRISPR-Cas9. CRISPR, short for clustered, regularly interspaced short palindromic…